Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Alterations in PTEN and ESR1 promote clinical resistance to alpelisib plus aromatase inhibitors.
Journal: Nature cancer
Published: August 31, 2020
Tumor PIK3CA Genotype and Prognosis in Early-Stage Breast Cancer: A Pooled Analysis of Individual Patient Data.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: February 23, 2018
ATM loss leads to synthetic lethality in BRCA1 BRCT mutant mice associated with exacerbated defects in homology-directed repair.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: June 30, 2017
Prevalence of ESR1 Mutations in Cell-Free DNA and Outcomes in Metastatic Breast Cancer: A Secondary Analysis of the BOLERO-2 Clinical Trial.
Journal: JAMA oncology
Published: August 18, 2016
Correlation between PIK3CA mutations in cell-free DNA and everolimus efficacy in HR+, HER2- advanced breast cancer: results from BOLERO-2.
Journal: British journal of cancer
Published: July 15, 2016
Phase III Trial Evaluating Letrozole As First-Line Endocrine Therapy With or Without Bevacizumab for the Treatment of Postmenopausal Women With Hormone Receptor-Positive Advanced-Stage Breast Cancer: CALGB 40503 (Alliance).
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 04, 2016
Robust homology-directed repair within mouse mammary tissue is not specifically affected by Brca2 mutation.
Journal: Nature communications
Published: April 05, 2016
PARP Inhibitors in Clinical Use Induce Genomic Instability in Normal Human Cells.
Journal: PloS one
Published: April 05, 2016
Phase II study of paclitaxel given once per week along with trastuzumab and pertuzumab in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: December 31, 2014
Reverse-Contrast Imaging and Targeted Radiation Therapy of Advanced Pancreatic Cancer Models.
Journal: International journal of radiation oncology, biology, physics
Published: December 04, 2014
A phase II open-label study of ganetespib, a novel heat shock protein 90 inhibitor for patients with metastatic breast cancer.
Journal: Clinical breast cancer
Published: September 13, 2013
Last Updated: 09/26/2026